Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,500
Closed -$123K 3167
2023
Q1
$123K Hold
16,500
﹤0.01% 3000
2022
Q4
$205K Buy
16,500
+3,360
+26% +$59K ﹤0.01% 2999
2022
Q3
$271K Sell
13,140
-720
-5% -$20K ﹤0.01% 2906
2022
Q2
$384K Sell
13,860
-23,870
-63% -$817K ﹤0.01% 2793
2022
Q1
$1.65M Buy
37,730
+25,040
+197% +$1.09M ﹤0.01% 2202
2021
Q4
$700K Hold
12,690
﹤0.01% 2606
2021
Q3
$784K Hold
12,690
﹤0.01% 2589
2021
Q2
$1.08M Hold
12,690
﹤0.01% 2498
2021
Q1
$1M Buy
12,690
+5,630
+80% +$366K ﹤0.01% 2411
2020
Q4
$411K Sell
7,060
-1,780
-20% -$83.8K ﹤0.01% 2678
2020
Q3
$300K Hold
8,840
﹤0.01% 2808
2020
Q2
$408K Buy
8,840
+5,740
+185% +$160K ﹤0.01% 2733
2020
Q1
$49K Buy
3,100
+1,060
+52% +$25.2K ﹤0.01% 3055
2019
Q4
$56K Hold
2,040
﹤0.01% 3090
2019
Q3
$60K Hold
2,040
﹤0.01% 3119
2019
Q2
$59K Buy
+2,040
New +$68.7K ﹤0.01% 3123

Other funds holding AFMD

AllianceBernstein's AFMD Position: Q2 2023 in Review

AllianceBernstein sold out of Affimed (AFMD) in Q2 2023, closing a stake of 16,500 shares — an estimated $123K sold.

AllianceBernstein first reported a position in AFMD in Q2 2019 and held it in 16 quarters. The position peaked at $1.65M in Q1 2022. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • AllianceBernstein reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • AllianceBernstein sold 16,500 Affimed shares in Q2 2023, an estimated $123K.
  • AllianceBernstein first reported a position in Affimed in Q2 2019 and held it in 16 quarters.
  • AllianceBernstein's Affimed position peaked at $1.65M in Q1 2022.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.